{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:08:10Z","timestamp":1774566490456,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,19]]},"DOI":"10.7759\/cureus.101868","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T21:06:41Z","timestamp":1768856801000},"source":"Crossref","is-referenced-by-count":1,"title":["Neuroleptic Malignant Syndrome Induced by Multiple Antipsychotics in a Patient Receiving Methadone"],"prefix":"10.7759","author":[{"given":"Naoki","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2404606","article-title":"Neuroleptic malignant syndrome","volume":"391","author":"Wijdicks EF","year":"2024","unstructured":"Wijdicks EF, Ropper AH. Neuroleptic malignant syndrome. N Engl J Med. 2024, 391:1130-8. 10.1056\/NEJMra2404606","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson JL","year":"1985","unstructured":"Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985, 142:1137-45. 10.1176\/ajp.142.10.1137","journal-title":"Am J Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff SN","year":"1993","unstructured":"Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993, 77:185-202. 10.1016\/s0025-7125(16)30278-4","journal-title":"Med Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2020-002200","article-title":"Neuroleptic malignant syndrome in patients with cancer: a systematic review","volume":"10","author":"Sato I","year":"2020","unstructured":"Sato I, Onishi H, Kawanishi C, Yamada S, Ishida M, Kawakami K. Neuroleptic malignant syndrome in patients with cancer: a systematic review. BMJ Support Palliat Care. 2020, 10:265-70. 10.1136\/bmjspcare-2020-002200","journal-title":"BMJ Support Palliat Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2022.04.176","article-title":"Physicians\u2019 beliefs and attitudes toward hypoactive delirium in the last days of life","volume":"64","author":"Oya K","year":"2022","unstructured":"Oya K, Morita T, Tagami K, Matsuda Y, Naito AS, Kashiwagi H, Otani H. Physicians\u2019 beliefs and attitudes toward hypoactive delirium in the last days of life. J Pain Symptom Manage. 2022, 64:110-8. 10.1016\/j.jpainsymman.2022.04.176","journal-title":"J Pain Symptom Manage"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(95)11364-3","article-title":"Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord","volume":"187","author":"Ebert B","year":"1995","unstructured":"Ebert B, Andersen S, Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett. 1995, 187:165-8. 10.1016\/0304-3940(95)11364-3","journal-title":"Neurosci Lett"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3940(97)13391-2","article-title":"The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord","volume":"223","author":"Gorman AL","year":"1997","unstructured":"Gorman AL, Elliott KJ, Inturrisi CE. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett. 1997, 223:5-8. 10.1016\/s0304-3940(97)13391-2","journal-title":"Neurosci Lett"},{"key":"ref8","article-title":"Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception","volume":"274","author":"Codd EE","year":"1995","unstructured":"Codd EE, Shank RP, Schupsky JJ, Raffa RB. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther. 1995, 274:1263-70.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2131","article-title":"Fentanyl-induced chest wall rigidity","volume":"143","author":"\u00c7oruh B","year":"2013","unstructured":"\u00c7oruh B, Tonelli MR, Park DR. Fentanyl-induced chest wall rigidity. Chest. 2013, 143:1145-6. 10.1378\/chest.12-2131","journal-title":"Chest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-3243","article-title":"Methadone-induced rigid-chest syndrome after substantial overdose","volume":"126","author":"Lynch RE","year":"2010","unstructured":"Lynch RE, Hack RA. Methadone-induced rigid-chest syndrome after substantial overdose. Pediatrics. 2010, 126:e232-4. 10.1542\/peds.2009-3243","journal-title":"Pediatrics"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1889","article-title":"Methadone-induced toxic leukoencephalopathy: MR imaging and MR proton spectroscopy findings","volume":"31","author":"Salgado RA","year":"2010","unstructured":"Salgado RA, Jorens PG, Baar I, Cras P, Hans G, Parizel PM. Methadone-induced toxic leukoencephalopathy: MR imaging and MR proton spectroscopy findings. AJNR Am J Neuroradiol. 2010, 31:565-6. 10.3174\/ajnr.A1889","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref12","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken MM","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982, 5:649-55.","journal-title":"Am J Clin Oncol"},{"key":"ref13","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). (2022). https.\/\/psychiatryonline.org\/doi\/epub\/10.1176\/appi.books.9780890425787."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.6.786","article-title":"Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study","volume":"160","author":"Lawlor PG","year":"2000","unstructured":"Lawlor PG, Gagnon B, Mancini IL, Pereira JL, Hanson J, Suarez-Almazor ME, Bruera ED. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med. 2000, 160:786-94. 10.1001\/archinte.160.6.786","journal-title":"Arch Intern Med"},{"key":"ref15","article-title":"Neuroleptic prescription pattern for delirium in patients with advanced cancer","volume":"27","author":"Hui D","year":"2011","unstructured":"Hui D, Reddy A, Palla S, Bruera E. Neuroleptic prescription pattern for delirium in patients with advanced cancer. J Palliat Care. 2011, 27:141-7.","journal-title":"J Palliat Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei210","article-title":"Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity","volume":"95","author":"Gillman PK","year":"2005","unstructured":"Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005, 95:434-41. 10.1093\/bja\/aei210","journal-title":"Br J Anaesth"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2000.102003226.x","article-title":"Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome","volume":"102","author":"Spivak B","year":"2000","unstructured":"Spivak B, Maline DI, Vered Y, et al.. Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome. Acta Psychiatr Scand. 2000, 102:226-30. 10.1034\/j.1600-0447.2000.102003226.x","journal-title":"Acta Psychiatr Scand"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/456489-neuroleptic-malignant-syndrome-induced-by-multiple-antipsychotics-in-a-patient-receiving-methadone","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T21:06:42Z","timestamp":1768856802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/456489-neuroleptic-malignant-syndrome-induced-by-multiple-antipsychotics-in-a-patient-receiving-methadone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.101868","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,19]]}}}